Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Bo Han

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Pharmacology|August 29, 2022
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studiesRuo-Lin Gao, Jun Song, Li Sun, et al.
Frontiers in Oncology|January 21, 2020
Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case ReportLe-Tian Huang, Jie-Tao Ma, Shu-Ling Zhang, et al.
Frontiers in Oncology|July 5, 2022
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysisXiao-Fang Yi, Jun Song, Ruo-Lin Gao, et al.
BMC Cancer|March 3, 2021
Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgeryShu-Ling Zhang, Jun Song, Yan-Ru Wang, et al.
Frontiers in Oncology|January 29, 2021
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical TrialsLi Sun, Yi-Jia Guo, Jun Song, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 StudiesJie-Tao Ma, Yang Liu, Li Sun, et al.
BMC Cancer|April 18, 2021
Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trialsLe-Tian Huang, Rui Cao, Yan-Ru Wang, et al.
Journal of Thoracic Disease|April 11, 2020
Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancersXiang-Yan Zhang, Rui Cao, Yi-Jia Guo, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Pharmacology|August 29, 2022
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studiesRuo-Lin Gao, Jun Song, Li Sun, et al.
Frontiers in Oncology|January 21, 2020
Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case ReportLe-Tian Huang, Jie-Tao Ma, Shu-Ling Zhang, et al.
Frontiers in Oncology|July 5, 2022
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysisXiao-Fang Yi, Jun Song, Ruo-Lin Gao, et al.
BMC Cancer|March 3, 2021
Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgeryShu-Ling Zhang, Jun Song, Yan-Ru Wang, et al.
Frontiers in Oncology|January 29, 2021
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical TrialsLi Sun, Yi-Jia Guo, Jun Song, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 StudiesJie-Tao Ma, Yang Liu, Li Sun, et al.
BMC Cancer|April 18, 2021
Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trialsLe-Tian Huang, Rui Cao, Yan-Ru Wang, et al.
Journal of Thoracic Disease|April 11, 2020
Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancersXiang-Yan Zhang, Rui Cao, Yi-Jia Guo, et al.
Pageof 5